Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone

Details for Australian Patent Application No. 2004273660 (hide)

International Classifications

Event Publications

23 March 2006 PCT application entered the National Phase

PCT publication WO2005/027915 Priority application(s): WO2005/027915

24 April 2008 Assignment before Grant

Pfizer Products Inc. The application has been assigned to Wisconsin Alumni Research Foundation (WARF)

19 August 2010 Application Accepted

Published as AU-B-2004273660

31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.